Role of inflammation in aerogenous progression of adenocarcinoma

M. Wislez (Paris, France)

Source: Annual Congress 2004 - Epithelial - microenvironmental interactions in neoplastic and non-neoplastic lung diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wislez (Paris, France). Role of inflammation in aerogenous progression of adenocarcinoma. Annual Congress 2004 - Epithelial - microenvironmental interactions in neoplastic and non-neoplastic lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of tumor stroma and inflammation on survival of stage I-IIp lung cancer
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017

Microscopic vessel invasion and visceral pleural invasion are correlated with EMT, cancer stemness and resistance to therapy in lung adenocarcinoma
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016

Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing
Source: Eur Respir J 2004; 24: 502-505
Year: 2004



Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


COPD-like inflammation drives the progression of K-ras induced early cancerous lesions
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Bronchial bacterial colonization in patients with resectable lung carcinoma
Source: Eur Respir J 2002; 19: 326-332
Year: 2002



Lung cancer: immunopathology
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48
Year: 2001

Angiogenesis in preinvasive, early invasive bronchial lesions and micropapillomatosis and correlation with EGF-R expression
Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity
Year: 2006


Elucidating progression of early cystic fibrosis lung disease
Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017
Year: 2017



Splenectomy inhibits tumor development and metastases in murine lung cancer models
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012


Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour
Source: Eur Respir J, 59 (1) 2101058; 10.1183/13993003.01058-2021
Year: 2022



Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Osteopontin promotes urethane-induced airway epithelial carcinogenesis
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009

The role of TTF-1 in differentiation of primary and metastatic adenocarcinomas of the lung
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

Function of PTEN/PI3k/AKT pathway in bronchioalveolar epithelium in the pathogenesis of lung fibrosis
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009

Investigation of biomarkers for pulmonary carcinomatous lymphangitis in patients with lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Visceral pleural invasion is an invasive and aggressive indicator of nonsmall cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=264
Year: 2006

Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018